Table 1.
Demographics and clinical and pathological data of the cohort.
| Variables | Data |
|---|---|
| Age, median (min, max) | 72.52 (51, 83) |
|
| |
| Sex, n (%) | |
|
| |
| Male, | 30 (75 %) |
| Female | 10 (25 %) |
|
| |
| Child Pugh Class, n (%) | |
|
| |
| A | 40 (100 %) |
| B | 0 |
| C | 0 |
|
| |
| Etiology, n (%) | |
|
| |
| HBV | 12 (30 %) |
| HCV | 13 (32.5 %) |
| Nonviral | 15 (37.5 %) |
|
| |
| Fibrosis grade, n (%) | |
|
| |
| 0-2 | 22 (55 %) |
| 3-4 | 18 (45 %) |
|
| |
| Tumor staging, n (%) | |
|
| |
| I-II | 28 (70 %) |
| III-IV | 12 (30 %) |
|
| |
| Tumor size, n (%) | |
|
| |
| < 5 cm | 27 (67.5 %) |
| ≥ 5 cm | 13 (32.5 %) |
|
| |
| Tumor number, n (%) | |
|
| |
| Single | 31 (77.5 %) |
| Multiple | 09 (22.5 %) |
|
| |
| Vascular invasion, n (%) | |
| Present | 08 (20 %) |
| Absent | 32 (80 %) |
|
| |
| Tumor histology (differentiation), n (%) | |
|
| |
| Well-to-moderate | 32 (80 %) |
| Poor | 08 (20 %) |
|
| |
| Type of hepatectomy, n (%) | |
|
| |
| Major hepatectomy | 14 (35 %) |
| Minor hepatectomy | 26 (65 %) |
|
| |
| Prior treatment, n (%) | |
|
| |
| RFA/TACE | 19 (47.5 %) |
| None | 21 (52. 5 %) |
|
| |
| Total bilirubin before resection, n (%) | |
|
| |
| < 1 mg/dl | 28 (70 %) |
| ≥ 1 mg/dl | 12 (30 %) |
|
| |
| INR before resection, n (%) | |
|
| |
| > 1 | 30 (75 %) |
| < 1 | 10 (25 %) |
|
| |
| AFP before resection, n (%) | |
|
| |
| < 20 ng/ml | 25 (62.5 %) |
| ≥ 20 ng/ml | 15 (37.5 %) |
|
| |
| Clavien-Dindo postoperative (severe) morbidity, n (%) | |
|
| |
| Absent | 35 (87.5 %) |
| Present | 05 (12.5 %) |
Min., minimum; max., maximum; n/N, numbers; HBV, hepatitis B virus; HCV, hepatitis C virus; INR, international normalized ratio, AFP, alpha-fetoprotein; PIVKA II, protein induced by vitamin K absence/antagonist-II; TACE, transarterial chemoembolization; RFA, radiofrequency ablation; INR, international normalized ratio.